INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve
Edwards Lifesciences, LLC · Decision date Oct 22, 2026
What did the FDA approve?
The FDA record identifies this as supplement P150048/S100 to Edwards Lifesciences' PMA P150048, filed under the Normal 180 Day Track No User Fee pathway with the reason "Location Change - Manufacturer/Sterilizer/Packager/Supplier." The decision, dated 2026-10-22, is APPR. The listed products are the INSPIRIS RESILIA Aortic Valve and MITRIS RESILIA Mitral Valve, non-allograft tissue heart valves under product code LWR in Cardiovascular.
The stated purpose is approval of a manufacturing site at CENTERPIECE, Bulevar La Encantada Industrial, Parque Industrial El Floride, Seccion La Encantada # 11530, Tijuana Baja California, Mexico 22250, for terminal ethylene oxide sterilization. That is a sterilization-site change within the existing PMA, not an approval of the whole valve system and not an original PMA. The record gives no sterilization cycle parameters, no validation data and no clinical or safety conclusions; the reported purpose should not be read as independent evidence of safety or effectiveness.
FDA approval order statement
approval for a manufacturing site located at CENTERPIECE (Bulevar La Encantada Industrial, Parque Industrial El Floride, Seccion La Encantada # 11530, Tijuana Baja California, Mexico 22250) for terminal ethylene oxide sterilization.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 22, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150048/S100
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- APPR
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150048. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150048 · Original PMA
EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)
P150048/S100 received
Application receipt date recorded by FDA.
P150048/S100 · FDA decision
Normal 180 Day Track No User Fee
P150048/S104 · Related supplement
INSPIRIS RESILIA Aortic Valve (11500A), KONECT RESILIA Aortic Valve Conduit (AVC) (11060A), MITRIS RESILIA Mitral Valv
Timeline entries are records held by MedtechLedger for P150048. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150048
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Jun 29, 2017 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Aug 12, 2016 | FDA | |
| ABBOTT MEDICAL | PMA approval | Aug 5, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150048/S100
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records